Join us on Friday, September 12th, 2025 for FASI’s 2025 Symposium! This year’s symposium, “Neurobiology & Immunology of Food-Related Behaviors and Eating Disorders,” aims to break new ground in understanding how immune responses shape our relationship with food—from taste perception to allergic reactions. To register, visit: https://lnkd.in/eAq_xXYx
Food Allergy Science Initiative
生物技术研究
Cambridge，Massachusetts 1,791 位关注者
Nation's leading nonprofit scientific research network catalyzing breakthrough discoveries to treat & cure food allergy
关于我们
Food allergies are a growing public health concern affecting 32 million Americans including 8% of children. Despite the prevalence of food allergies, very limited progress in diagnostics and treatments has been made over the past 40 years. Since its inception, FASI has made tremendous progress in advancing our knowledge of food allergies, pioneering important new research discoveries in the gut-brain axis, and?forming an interdisciplinary research team of world-leading scientists to unlock the mystery of food allergies. Founded in 2016 at the Broad Institute of MIT and Harvard, the Food Allergy Science Initiative (FASI) was spun out in 2021 with the mission of uncovering the root causes of food allergies through rigorous scientific research and deploying new therapies to treat and ultimately cure them. FASI is an independent 501(c)(3) organization?that encompasses 20 world-class labs across the U.S. and includes more than 100 researchers coordinated across diverse fields from immunology and neuroscience to computational biology and engineering. Learn more at www.foodallergyscience.org
- 网站
-
https://www.foodallergyscience.org
Food Allergy Science Initiative的外部链接
- 所属行业
- 生物技术研究
- 规模
- 2-10 人
- 总部
- Cambridge，Massachusetts
- 类型
- 非营利机构
- 创立
- 2016
- 领域
- scientific research、food allergy、allergy、immunology、science、research、R&D、drug development、biopharma、biotech、life sciences、neurology、neuroscience、computational biology、engineering、genomics、microbiome、CNS、chemistry、biology、nervous system、immunotherapy和diagnostics
地点
-
主要
获取路线
105 Broadway
US，Massachusetts，Cambridge
Food Allergy Science Initiative员工
-
Carlos Bosques
Chief Executive Officer | Strategic Scientific Leader | Working at the interface of Immunology, Neuroscience, Gastroenterology and Microbiology to…
-
Christine Olsen
FASI Co-founder | Executive Chair, Board of Directors | Translational Science Leader | Radiation Oncologist | Allergy Mom
-
Megan Fisklements
FoodTech Innovator | Data Science/AI Adjacent | Early Stage Startups | Leadership and Strategy | 10+ Years of Translating Novel Ingredients &…
-
Christopher "CJ" Beneduce
Principal Scientist at the Food Allergy Science Initiative
动态
-
At FASI, we have brought together a team of experts from some of the world’s leading institutions to uncover the fundamental mechanisms of food allergies. By breaking down scientific silos, we are focused on understanding the connection between the immune and nervous systems, aiming to identify the true causes of allergies and develop treatments that prevent reactions before they occur. #FoodAllergies #FoodAllergyResearch #FoodAllergyAwareness
-
-
Our team is tackling essential questions: How does the microbiome interact with the immune system? What role does it play in nutrient processing and allergen detection? And how does it influence susceptibility to allergies? Learn how we are advancing our understanding of these critical areas: https://lnkd.in/eQFMFM4y #FoodAllergies #FoodAllergyResearch #FoodAllergyScience #ImmuneSystem
-
-
Join us today at 12 PM ET for our seminar with Tim Moran, M.D., Ph.D., Associate Professor of Pediatric Allergy, Immunology, and Rheumatology at the University of North Carolina School of Medicine. Dr. Moran?will join FASI CEO, Carlos Bosques, Ph.D. for an exciting discussion on Selected Effects of Known Chemicals in our Environment, Mechanisms of Sensitization & Exposure. To register, click here:?https://lnkd.in/eJncub2i #foodallergy?#research?#foodallergyawareness?
-
-
In honor of #InternationalWomensDay, we celebrate the women driving change and innovation in food allergy research. Our co-founder and executive chair, Christine Olsen, established FASI after her son’s anaphylactic reaction to sesame. She united experts to explore the mechanisms of food allergies and advance diagnostics, prevention, and treatment. Join us today in honoring the women leading the way in food allergy science. #IWD2025 #AccelerateAction #FoodAllergyScience #WomeninScience
-
-
Conducted by researchers at the Icahn School of Medicine at Mount Sinai and funded by the The National Institutes of Health, this study suggests that gradually increasing daily doses of peanut butter over 18 months can improve tolerance to peanuts. These exciting findings can help open the gateway to potential personalized treatments that can be a game-changer for the majority of people with food allergies. #FoodAllergy #FoodAllergyResearch #PeanutAllergy?
In an NIH-supported clinical trial, researchers found that eating increasing doses of store-bought, home-measured peanut butter for 1.5 yrs. enabled kids with peanut allergy who initially could tolerate at least ? a peanut to eat 3 Tbsp. of peanut butter without an allergic reaction. Read more: https://lnkd.in/eMXvqDAs #FoodAllergy #PeanutButter #NutAllergy #ClinicalTrial #research #NIH
-
?? This past weekend at the AAAAI/WAO Joint Congress, FASI had the pleasure of connecting with our esteemed colleagues from the Food Allergy Nursing Association (FANA), the Alpha-Gal Foundation, and The FAACT, Food Allergy & Anaphylaxis Connection Team. We truly appreciate the insightful conversations and shared knowledge during the event. Together, we are advancing the mission of food allergy awareness and support! #AAAAI #WAO #FoodAllergies #Partnership #CommunityEngagement #Awareness #FANA #AlphaGalFoundation #FAACT
Chief Executive Officer | Strategic Scientific Leader | Working at the interface of Immunology, Neuroscience, Gastroenterology and Microbiology to discover & develop therapies for food allergies and associated diseases.
It was great meeting our friends from the Food Allergy Nursing Association (FANA), the Alpha-Gal Foundation and The FAACT, Food Allergy & Anaphylaxis Connection Team at the AAAAAI/WAO Joint Congress this past weekend, hosted by the American Academy of Allergy, Asthma, and Immunology and the World Allergy Organization. Thank you for all the great discussions! #FoodAllergyAwareness #AllergyAdvocacy #Education #FASI #AAAAAI #WAO #FoodAllergyNursingAssociation #AlphaGalFoundation #FAACT
-
-
?? FASI is thrilled to share that CEO Carlos Bosques had the opportunity to connect with Tamara Hubbard, MA, LCPC at the AAAAI / WAO Joint Congress in San Diego over the weekend! Tamara is set to release an exciting book this fall, designed to empower parents of children managing food allergies. Her work aims to help families navigate the complexities of food allergies while addressing their own anxieties. The FASI team looks forward to seeing the positive impact of her insights in our community! #AAAAI #WAO #FoodAllergies #Parenting #MentalHealth #AnxietyManagement #BookLaunch #AllergyAwareness #CommunitySupport
-
-
?? Exciting News in Food Allergy Research! ?? A recent #NIAID-funded clinical trial has found that omalizumab, marketed as Xolair, treats multi-food allergies more effectively than oral immunotherapy (OIT). While OIT carries a high risk of allergic reactions and side effects—leading to nearly 25% of participants discontinuing treatment—omalizumab significantly reduces these issues, making OIT safer and more tolerable. At FASI, our mission is clear: to eliminate food allergies altogether. Innovations like these bring us one step closer, enhancing the safety and effectiveness of treatments for those living with food allergies. We are committed to supporting research that paves the way for a future where food allergies are a thing of the past. Stay tuned for more updates as we continue to advocate for breakthroughs in food allergy treatments! ?? #FoodAllergyResearch #Omalizumab #Xolair #FASI #EndFoodAllergies
The medication omalizumab, marketed as Xolair, treated multi-food allergy more effectively than oral immunotherapy (OIT) in people with allergic reactions to very small amounts of common food allergens, a #NIAID-funded clinical trial has found. Researchers attributed this difference primarily to the high rate of allergic reactions and other intolerable side effects among the study participants who received OIT, leading a quarter of them to discontinue treatment. Omalizumab and OIT were equally effective among participants who completed treatment. Learn more: https://go.nih.gov/dYNo5T5 #NIH #research #ResearchAdvance #FoodAllergy #FoodAllergies #allergic #allergy #immunotherapy #OIT #FoodAllergyTreatment #omalizumab Johns Hopkins Children's Center Stanford University School of Medicine Genentech
-
-
Join us on March 11th at 12 PM ET for our seminar with Tim Moran, M.D., Ph.D., Associate Professor of Pediatric Allergy, Immunology, and Rheumatology at the University of North Carolina School of Medicine. Dr. Moran?will join FASI CEO, Carlos Bosques, Ph.D. for an exciting discussion on Selected Effects of Known Chemicals in our Environment, Mechanisms of Sensitization & Exposure. To register, click here:?https://lnkd.in/eJncub2i #foodallergy?#research?#foodallergyawareness?
-